lobbying_activities: 3170607

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3170607	146212d0-7983-46f8-b700-8c8448abba06	Q1	AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY	1386	AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY	2024	first_quarter	TOB	1/9/24 Coalition to letter to Chairs and Ranking Members of the House and Senate Committees on Appropriations urging that appropriations for FY 2024 retain the FDA's authority to regulate tobacco products and do not cut funding from the CDC's Office on Smoking and Health (OSH). 3/25/24 Coalition letter to the Chair and Ranking Member of the Senate Subcommittee on Labor, Health and Human Services, Education and Related Agencies to fund the CDC's Office on Smoking and Health (OSH) at $310 million for FY 2025. 3/25/24 Coalition letter to the Chair and Ranking Member of the House Subcommittee on Labor, Health and Human Services, Education and Related Agencies to fund the CDC's Office on Smoking and Health (OSH) at $310 million for FY 2025. Issues pertaining to tobacco control, including the pending FDA rule on prohibiting menthol cigarettes, and in general.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE		270000	0	0	2024-04-22T14:32:06-04:00